Cargando…

CT Perfusion ASPECTS in the Evaluation of Acute Ischemic Stroke: Thrombolytic Therapy Perspective

BACKGROUND AND PURPOSE: Advances in the management of acute ischemic stroke and medical imaging are creating pressure to replace the rigid one-third middle cerebral artery (MCA) and non-contrast-enhanced CT (NCCT) Alberta Stroke Program Early CT Score (ASPECTS) thresholds used for the selection of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Sillanpaa, Niko, Saarinen, Jukka T., Rusanen, Harri, Hakomaki, Jari, Lahteela, Arto, Numminen, Heikki, Elovaara, Irina, Dastidar, Prasun, Soimakallio, Seppo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343752/
https://www.ncbi.nlm.nih.gov/pubmed/22566978
http://dx.doi.org/10.1159/000324324
_version_ 1782231838863917056
author Sillanpaa, Niko
Saarinen, Jukka T.
Rusanen, Harri
Hakomaki, Jari
Lahteela, Arto
Numminen, Heikki
Elovaara, Irina
Dastidar, Prasun
Soimakallio, Seppo
author_facet Sillanpaa, Niko
Saarinen, Jukka T.
Rusanen, Harri
Hakomaki, Jari
Lahteela, Arto
Numminen, Heikki
Elovaara, Irina
Dastidar, Prasun
Soimakallio, Seppo
author_sort Sillanpaa, Niko
collection PubMed
description BACKGROUND AND PURPOSE: Advances in the management of acute ischemic stroke and medical imaging are creating pressure to replace the rigid one-third middle cerebral artery (MCA) and non-contrast-enhanced CT (NCCT) Alberta Stroke Program Early CT Score (ASPECTS) thresholds used for the selection of patients eligible for intravenous thrombolytic therapy. The identification of potentially salvageable ischemic brain tissue lies at the core of this issue. In this study, the role of CT perfusion ASPECTS in the detection of reversible ischemia was analyzed. MATERIALS AND METHODS: We retrospectively reviewed the clinical and imaging data of 92 consecutive patients who received intravenous thrombolytic therapy for acute (duration <3 h) ischemic stroke. Most of the patients underwent admission multimodal CT, and all patients had follow-up NCCT at 24 h. ASPECTS was assigned to all modalities and correlated with clinical and imaging parameters. Receiver-operating characteristic curve analysis was performed to determine optimal thresholds for different parameters to predict clinical outcome. RESULTS: A perfusion defect could be detected in 50% of the patients. ASPECTS correlated inversely with the clinical outcome in the following order: follow-up NCCT > cerebral blood volume (CBV) > mean transit time (MTT) > admission NCCT. The follow-up NCCT and the CBV displayed a statistically significant difference from the admission NCCT, while the MTT did not reach statistical significance. The threshold that best differentiated between good and bad clinical outcome on admission was CBV ASPECTS ≥7. In patients with CT perfusion ASPECTS mismatch, MTT and CBV ASPECTS essentially provided the lower and upper limits for the follow-up NCCT ASPECTS, thus defining the spectrum of possible outcomes. Furthermore, CT perfusion ASPECTS mismatch strongly correlated (r = 0.83) with the mismatch between the tissue at risk and the final infarct, i.e. the amount of salvaged tissue. This finding suggests that the CT perfusion ASPECTS mismatch adequately identifies the amount of potentially salvageable ischemic brain tissue. CONCLUSIONS: Parameters derived from the use of CT perfusion ASPECTS can detect reversible ischemia and are correlated with clinical outcome.
format Online
Article
Text
id pubmed-3343752
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-33437522012-05-07 CT Perfusion ASPECTS in the Evaluation of Acute Ischemic Stroke: Thrombolytic Therapy Perspective Sillanpaa, Niko Saarinen, Jukka T. Rusanen, Harri Hakomaki, Jari Lahteela, Arto Numminen, Heikki Elovaara, Irina Dastidar, Prasun Soimakallio, Seppo Cerebrovasc Dis Extra Original Paper BACKGROUND AND PURPOSE: Advances in the management of acute ischemic stroke and medical imaging are creating pressure to replace the rigid one-third middle cerebral artery (MCA) and non-contrast-enhanced CT (NCCT) Alberta Stroke Program Early CT Score (ASPECTS) thresholds used for the selection of patients eligible for intravenous thrombolytic therapy. The identification of potentially salvageable ischemic brain tissue lies at the core of this issue. In this study, the role of CT perfusion ASPECTS in the detection of reversible ischemia was analyzed. MATERIALS AND METHODS: We retrospectively reviewed the clinical and imaging data of 92 consecutive patients who received intravenous thrombolytic therapy for acute (duration <3 h) ischemic stroke. Most of the patients underwent admission multimodal CT, and all patients had follow-up NCCT at 24 h. ASPECTS was assigned to all modalities and correlated with clinical and imaging parameters. Receiver-operating characteristic curve analysis was performed to determine optimal thresholds for different parameters to predict clinical outcome. RESULTS: A perfusion defect could be detected in 50% of the patients. ASPECTS correlated inversely with the clinical outcome in the following order: follow-up NCCT > cerebral blood volume (CBV) > mean transit time (MTT) > admission NCCT. The follow-up NCCT and the CBV displayed a statistically significant difference from the admission NCCT, while the MTT did not reach statistical significance. The threshold that best differentiated between good and bad clinical outcome on admission was CBV ASPECTS ≥7. In patients with CT perfusion ASPECTS mismatch, MTT and CBV ASPECTS essentially provided the lower and upper limits for the follow-up NCCT ASPECTS, thus defining the spectrum of possible outcomes. Furthermore, CT perfusion ASPECTS mismatch strongly correlated (r = 0.83) with the mismatch between the tissue at risk and the final infarct, i.e. the amount of salvaged tissue. This finding suggests that the CT perfusion ASPECTS mismatch adequately identifies the amount of potentially salvageable ischemic brain tissue. CONCLUSIONS: Parameters derived from the use of CT perfusion ASPECTS can detect reversible ischemia and are correlated with clinical outcome. S. Karger AG 2011-02-17 /pmc/articles/PMC3343752/ /pubmed/22566978 http://dx.doi.org/10.1159/000324324 Text en Copyright © 2011 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Original Paper
Sillanpaa, Niko
Saarinen, Jukka T.
Rusanen, Harri
Hakomaki, Jari
Lahteela, Arto
Numminen, Heikki
Elovaara, Irina
Dastidar, Prasun
Soimakallio, Seppo
CT Perfusion ASPECTS in the Evaluation of Acute Ischemic Stroke: Thrombolytic Therapy Perspective
title CT Perfusion ASPECTS in the Evaluation of Acute Ischemic Stroke: Thrombolytic Therapy Perspective
title_full CT Perfusion ASPECTS in the Evaluation of Acute Ischemic Stroke: Thrombolytic Therapy Perspective
title_fullStr CT Perfusion ASPECTS in the Evaluation of Acute Ischemic Stroke: Thrombolytic Therapy Perspective
title_full_unstemmed CT Perfusion ASPECTS in the Evaluation of Acute Ischemic Stroke: Thrombolytic Therapy Perspective
title_short CT Perfusion ASPECTS in the Evaluation of Acute Ischemic Stroke: Thrombolytic Therapy Perspective
title_sort ct perfusion aspects in the evaluation of acute ischemic stroke: thrombolytic therapy perspective
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343752/
https://www.ncbi.nlm.nih.gov/pubmed/22566978
http://dx.doi.org/10.1159/000324324
work_keys_str_mv AT sillanpaaniko ctperfusionaspectsintheevaluationofacuteischemicstrokethrombolytictherapyperspective
AT saarinenjukkat ctperfusionaspectsintheevaluationofacuteischemicstrokethrombolytictherapyperspective
AT rusanenharri ctperfusionaspectsintheevaluationofacuteischemicstrokethrombolytictherapyperspective
AT hakomakijari ctperfusionaspectsintheevaluationofacuteischemicstrokethrombolytictherapyperspective
AT lahteelaarto ctperfusionaspectsintheevaluationofacuteischemicstrokethrombolytictherapyperspective
AT numminenheikki ctperfusionaspectsintheevaluationofacuteischemicstrokethrombolytictherapyperspective
AT elovaarairina ctperfusionaspectsintheevaluationofacuteischemicstrokethrombolytictherapyperspective
AT dastidarprasun ctperfusionaspectsintheevaluationofacuteischemicstrokethrombolytictherapyperspective
AT soimakallioseppo ctperfusionaspectsintheevaluationofacuteischemicstrokethrombolytictherapyperspective